China hospitals using non-invasive EEG BCIs in stroke and motor recovery rehabilitation — People's Daily reports growing clinical use
Summary
People's Daily Online reported growing clinical use of brain-computer interface systems in stroke and motor recovery rehabilitation programs across Chinese hospitals, with hospitals using non-invasive EEG-based BCIs to translate patients' movement intentions into limb activation and strengthen brain-body connectivity. The report, cited in Neurotech Notables #53, reflects China's rapid BCI clinical deployment following the NMPA commercial approval of Neuracle NEO in March 2026 and the provincial medical service pricing established in Sichuan, Hubei, and Zhejiang. China is now the only country where BCI therapy is available with insurance reimbursement coverage at the provincial level.
Why it matters
China's hospitals deploying non-invasive EEG BCI for stroke rehabilitation at scale — ahead of any Western country in clinical implementation — reflects the combination of NMPA commercial approval, provincial insurance pricing, and the manufacturing ecosystem that makes Chinese BCI products accessible at clinical scale. This is the first reported evidence of population-level BCI deployment for stroke rehabilitation anywhere in the world.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial